期刊
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
卷 43, 期 5, 页码 553-572出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.injury.2010.12.030
关键词
FDA; Peripheral nerve regeneration; Nerve repair; Grafting; Nerve guide conduit; Nerve protectant wrap; NeuraGen (R); Neurawrap (TM); NeuroMatrix (TM); Neuroflex (TM); Neuromed (TM); Neurotube (R); Neurolac (R); AxoGuard (TM); Surgisis (R); Hydrosheath (TM)
资金
- Enterprise Ireland [PC/2008/315]
Several nerve guidance conduits (NGCs) and nerve protectant wraps are approved by the US Food and Drug Administration (FDA) for clinical use in peripheral nerve repair. These devices cover a wide range of natural and synthetic materials, which may or may not be resorbable. This review consolidates the data pertaining to all FDA approved materials into a single reference, which emphasizes material composition alongside pre-clinical and clinical safety and efficacy (where possible). This article also summarizes the key advantages and limitations for each material as noted in the literature (with respect to the indication considered). In this context, this review provides a comprehensive reference for clinicians which may facilitate optimal material/device selection for peripheral nerve repair. For materials scientists, this review highlights predicate devices and evaluation methodologies, offering an insight into current deficiencies associated with state-of-the-art materials and may help direct new technology developments and evaluation methodologies thereof. (C) 2011 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据